Brett Bielory, MD
Brett P. Bielory, M.D., is an ophthalmologist who specializes in corneal transplantation, refractive surgery and ocular surface disease. He implements a customized, patient-centered approach incorporating surgical and non-surgical options to help patients choose their best treatment plan for corneal, refractive, and functional concerns of the eYes. Dr. Bielory is an innovator and enthusiastic teacher who loves bridging the gap between basic science, clinical practice and patient compassion. Dr. Bielory has published over 2 articles and book chapters in the field of ocular surface disease and has a keen interest in ocular allergy. Dr. Bielory combines his clinical care passion, scientific drive and innovative creativity to provide first-class, comprehensive care with a focus on ocular surface disease management.
- Eagle Scout, Boy Scouts of America, 2000
- Undergraduate & Graduate
- University of Michigan - Ann Arbor, BA: 2006
- Medical Education
- Technion - Israel Institute of Technology, Rappaport Faculty of Medicine, Haifa, Israel 2010
- Overlook Hospital, Atlantic Health System, Mount Sinai School of Medicine Affiliate 2013
- New York Medical College, Ophthalmology 2017
- Overlook Hospital, Atlantic Health System, Mount Sinai School of Medicine Affiliate, Internal Medicine 2013
- Tufts University/New England Eye Center, Cornea and Refractive Surgery 2018
- University of Miami- Miller School of Medicine, Ocular Pathology and Bascom Palmer Eye Institute 2012
- Board Certifications
- American Board of Ophthalmology, 2021
- New York Eye and Ear Infirmary, New York, NY; Mount Sinai School of Medicine, New York NY; Hackensack University Medical Center, Hackensack, NJ; Saint Barnabas University Medical Center; Clara Maas Medical Center, Belleville, NJ;
- American Academy of Ophthalmology (AAO); American Society for Cataract and Refractive Surgeons (ASCRS); Refractive Surgery Alliance (RSA); Association for Research in Vision and Ophthalmology (ARVO)
1. Kaur S, Teibel ZR, Farhat N, Atoot A, Bielory B. (2021)Chlamydia trachomatis Mimicking COVID-19 Chronic Follicular Conjunctivitis. Case Rep Ophthalmol Med. Jan 30;2021:6654347.
2. Seoul, Lee R, Bielory BP.(2020) Ophthalmic manifestations and management of com-mon and rare autoimmune syndromes. Curr Opin Allergy Clin Immunol 2020 Oct;20(5):493-500.
3.Bielory BP, Dubovy SR, Donaldsom KE, et al.(2016)Toxic Anterior Segment Syndrome: Inadvertent Administration of Intracameral Lidocaine 1% and Phenylephrine 2.5% Pre-served with 10% Benzalkonium Chloride During Cataract Surgery Cornea. 2017 May;36(5):621-624.
4. Bielory BP, O’Brien TP, et al. (2016). “Emerging Therapeutics for Ocular Surface Dis-ease.” Submitted for CurrOpin Allergy ClinImmunol 2016 Oct;16(5):477-86.
5. Bielory BP, Bielory L. (2014) “Over-the-counter migration of steroid use: impact on the eye.” CurrOpin Allergy ClinImmunol 2014 Oct;14 (5): 471-6.
6. Samimi DB, Bielory BP, Miller D, Johnson T. "Microbiology and Biofilm Trends of Sili-cone Lacrimal Implants: Comparing Infected Versus Routinely Removed Stents." Ophthal Plast Reconstruct Surg. 2016 Nov/Dec;32(6):452-457.
7. Samimi, DB, Bielory BP, Miller D, Johnson T, et al. (2013) “Microbiological Trends and Biofilm Growth on Explanted Periorbital Biomaterials: A 30-Year Re-view”OphthalPlastReconstr Surg. 2013 Sep;29(5):376-81